# Ernexa Therapeutics Inc.: Form SC 13D, filed Nov 21, 2018

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SC 13D
- Filed: 2018-11-21
- Accepted by EDGAR: Nov 21, 2018, 14:13 ET
- Period: not reported
- Accession: 0001062993-18-004781
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000106299318004781/schedule13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000106299318004781/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000106299318004781/schedule13d.htm

Filed Nov 21, 2018.
Source: SEC EDGAR, the filing index for accession 0001062993-18-004781. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.